U.K. Industry Asks For More Time To Prepare For Limits On OTC PSE Sales
This article was originally published in The Tan Sheet
Executive Summary
U.K. drug firms say the country's regulatory agency is not allowing enough time to comply with an order banning nonprescription access to product packages with more than 720 mg of pseudoephedrine beginning April 1